Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Nakayama

Showing results (41-50 of 174) with videos related to

Pageof 18
Sort By:
Oncology|March 5, 2011
Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancerMasako Ishikawa, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[A case of postoperative rapid brain metastasis originating from stage II a cervical adenosquamous cell carcinoma]Masako Ishikawa, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Cancer Letters|January 24, 2002
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinomaKentaro Nakayama, Atsuko Kanzaki, Kohkichi Hata, et al.
Gynecologic Oncology|April 16, 2003
Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinomaRitsuto Fujiwaki, Kohji Iida, Kentaro Nakayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancerMasako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, et al.
The Journal of Obstetrics and Gynaecology Research|October 10, 2013
Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: analysis of treatment results at a single facilityKentaro Nakayama, Tomoka Ishibashi, Masako Ishikawa, et al.
Cancers|May 28, 2022
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome ResistanceSatoru Kyo, Kosuke Kanno, Masahiro Takakura, et al.
Oncology Letters|April 29, 2016
Efficacy of microwave ablation for the treatment of endometrial carcinoma: A report of 3 casesKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot StudySultana Razia, Kentaro Nakayama, Hitomi Yamashita, et al.
Journal of Shoulder and Elbow Surgery|August 28, 2021
Prevalence and associated factors of primary elbow osteoarthritis in the Japanese general elderly population: a Japanese cohort survey randomly sampled from a basic resident registryKentaro Nakayama, Hiroyuki Kato, Shota Ikegami, et al.
Pageof 18

Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
Oncology|March 5, 2011
Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancerMasako Ishikawa, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[A case of postoperative rapid brain metastasis originating from stage II a cervical adenosquamous cell carcinoma]Masako Ishikawa, Kentaro Nakayama, Mohammed Tanjimur Rahman, et al.
Cancer Letters|January 24, 2002
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) gene expression in human ovarian carcinomaKentaro Nakayama, Atsuko Kanzaki, Kohkichi Hata, et al.
Gynecologic Oncology|April 16, 2003
Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinomaRitsuto Fujiwaki, Kohji Iida, Kentaro Nakayama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancerMasako Ishibashi, Kentaro Nakayama, Shamima Yeasmin, et al.
The Journal of Obstetrics and Gynaecology Research|October 10, 2013
Microwave endometrial ablation at a frequency of 2.45 GHz for menorrhagia: analysis of treatment results at a single facilityKentaro Nakayama, Tomoka Ishibashi, Masako Ishikawa, et al.
Cancers|May 28, 2022
Clinical Landscape of PARP Inhibitors in Ovarian Cancer: Molecular Mechanisms and Clues to Overcome ResistanceSatoru Kyo, Kosuke Kanno, Masahiro Takakura, et al.
Oncology Letters|April 29, 2016
Efficacy of microwave ablation for the treatment of endometrial carcinoma: A report of 3 casesKohei Nakamura, Kentaro Nakayama, Masako Ishikawa, et al.
Current Oncology (Toronto, Ont.)|May 15, 2023
Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot StudySultana Razia, Kentaro Nakayama, Hitomi Yamashita, et al.
Journal of Shoulder and Elbow Surgery|August 28, 2021
Prevalence and associated factors of primary elbow osteoarthritis in the Japanese general elderly population: a Japanese cohort survey randomly sampled from a basic resident registryKentaro Nakayama, Hiroyuki Kato, Shota Ikegami, et al.
Pageof 18